By analyzing Sema3E expression in three separate sources of patient samples, we found that Sema3E was overexpressed in pancreatic cancer, and that patient samples expressing high levels of Sema3E were associated with poor survival. Here, SEMA3E is linked to pancreatic neoplasm.